Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| UnitedHealth Group Inc. | 79 | 4 | 12 | 2 | €302.60 | €331.06 | 9.406% |
| Eli Lilly Corp. | 71 | 3 | 7 | 1 | €740.90 | €992.11 | 33.905% |
| Insmed Inc. | 66 | 1 | 6 | 1 | ? | €173.11 | 52.175% |
| Abbott Laboratories | 63 | 0 | 23 | 0 | €79.22 | €117.48 | 48.295% |
| Intuitive Surgical Inc | 60 | 2 | 13 | 0 | €401.85 | €517.02 | 28.660% |
| Gilead Sciences Inc | 53 | 0 | 3 | 0 | €108.98 | €125.00 | 14.700% |
| HCA Holdings Inc. | 52 | 0 | 7 | 0 | €380.40 | €443.46 | 16.576% |
| Ionis Pharmaceuticals Inc. | 52 | 1 | 3 | 0 | €62.54 | €77.25 | 23.523% |
| Neurocrine Bioscience | 51 | 0 | 6 | 0 | €109.30 | €148.52 | 35.881% |
| Tenet Healthcare | 47 | 0 | 0 | 0 | €158.00 | €193.52 | 22.483% |
| Alnylam Pharmace. | 46 | 0 | 1 | 0 | €260.80 | €428.30 | 64.225% |
| Vertex Pharmaceuticals Inc. | 46 | 0 | 1 | 0 | €363.45 | €458.50 | 26.153% |
| Regeneron Pharmaceuticals Inc. | 45 | 0 | 5 | 0 | €635.30 | €705.36 | 11.028% |
| Johnson & Johnson | 45 | 1 | 12 | 0 | €192.24 | €215.09 | 11.887% |
| Dexcom Inc. | 43 | 1 | 0 | 0 | €52.40 | €77.13 | 47.195% |
| Cytokinetics Inc. | 40 | 0 | 2 | 0 | €52.58 | €71.95 | 36.831% |
| Rhythm Pharmaceuticals | 41 | 1 | 0 | 1 | ? | €109.86 | 52.578% |
| Cigna Corp. | 37 | 0 | 1 | 0 | €241.20 | €306.38 | 27.021% |
| Jazz Pharmaceuticals plc | 36 | 0 | 1 | 0 | €171.75 | €177.05 | 3.088% |
| Thermo Fisher Scientific Inc. | 34 | 0 | 6 | 0 | €399.40 | €523.69 | 31.118% |
| Edwards Lifesciences Corp. | 33 | 0 | 4 | 0 | €71.20 | €81.28 | 14.160% |
| Acadia Pharmaceuticals | 34 | 1 | 0 | 0 | €19.03 | €28.15 | 47.975% |
| Amgen Inc. | 35 | 3 | 2 | 0 | €290.25 | €312.46 | 7.650% |
| AbbVie Inc. | 30 | 0 | 2 | 0 | €168.40 | €211.50 | 25.592% |
| United Therapeutics | 30 | 1 | 4 | 0 | €484.10 | €507.66 | 4.867% |